In:
Cancer, Wiley, Vol. 126, No. 10 ( 2020-05-15), p. 2163-2173
Abstract:
Circulating cell‐free Epstein‐Barr virus (EBV) DNA levels in the plasma can be useful for detecting tumor recurrence early after treatment in patients with nasopharyngeal carcinoma, particularly those with extrapulmonary metastases. Positive circulating cell‐free EBV DNA can be detected at a median of 2.3 months before radiological or clinical evidence of disease recurrence is noted.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink